| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/24/2008 | US20080175796 Delivery of Drug Esters Through an Inhalation Route |
| 07/24/2008 | CA2675733A1 Method for glycosylation of flavonoid compounds |
| 07/24/2008 | CA2675520A1 New combination for use in the treatment of inflammatory disorders |
| 07/24/2008 | CA2674865A1 Indole derivative having i.kappa.b kinase .beta. inhibitory activity |
| 07/24/2008 | CA2674678A1 Morpholine dopamine agonists for the treatment of pain |
| 07/24/2008 | CA2672425A1 Galenic form for the transmucosal delivery of paracetamol |
| 07/23/2008 | EP1947178A1 Human monoclonal antibody binding to human gm-csf and antigen-binding site thereof |
| 07/23/2008 | EP1947100A1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 07/23/2008 | EP1946776A1 Stabilized TNFR-Fc composition comprising arginine |
| 07/23/2008 | EP1946754A1 Therapeutic agent for ulcerative colitis and/or crohn's disease |
| 07/23/2008 | EP1945646A1 Pyrimidine compounds for the treatment of inflammatory disorders |
| 07/23/2008 | EP1945642A1 Pyrazolo-pyrimidine derivatives as anti-inflammatory agents |
| 07/23/2008 | EP1945626A1 Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists |
| 07/23/2008 | EP1945616A1 Cinnoline compounds as inhibitors of phosphodiesterase type iv (pde4) |
| 07/23/2008 | EP1945226A2 Drug composition with analgesic, anti-inflammatory and decongestive activity |
| 07/23/2008 | EP1945219A2 Compound |
| 07/23/2008 | EP1945029A2 Inhibitors of ion channels |
| 07/23/2008 | EP1569933B1 Pyrrolidine and azetidine compounds as ccr5 antagonists |
| 07/23/2008 | EP1490367B1 Imidazopyridine derivatives as kinase inhibitors |
| 07/23/2008 | EP1471901B1 Spermidine derivative for the treatment of chronic neurodegenerative diseases |
| 07/23/2008 | EP1453743B1 Pharmaceutical product and method with an adsorbent |
| 07/23/2008 | EP1412361B1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 07/23/2008 | EP1382603B1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof |
| 07/23/2008 | EP1372696B1 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 07/23/2008 | EP1218369B1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/23/2008 | EP1126830B1 Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 07/23/2008 | EP1071680B1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 07/23/2008 | CN101228175A Thiocolchicoside analogues with myorelaxant and anti-inflammatory activity |
| 07/23/2008 | CN101228171A Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase |
| 07/23/2008 | CN101228145A Organic compounds for the treatment of inflammatory or allergic conditions |
| 07/23/2008 | CN101228139A Substituted benzo[d]isoxazol-3-yl amine compounds as analgesics |
| 07/23/2008 | CN101227901A Anti-inflammatory agents |
| 07/23/2008 | CN101227893A Novel pharmaceutical modified release dosage form composition comprising cyclooxygenase enzyme inhibitor |
| 07/23/2008 | CN101225146A Chitosan-ketoprofen grafts and preparation method thereof |
| 07/23/2008 | CN101224279A Medicine compound for treating urinary infection and preparing method thereof |
| 07/23/2008 | CN101224267A Chinese traditional medicine for treating rheumatism, rheumatism-like, hyperosteogeny |
| 07/23/2008 | CN101224261A Chinese medicine compound for treating chronic medullitis and preparing method thereof |
| 07/23/2008 | CN101224244A Children clearing heat suppository and preparing method thereof |
| 07/23/2008 | CN101224242A Application of rumex japonicus in preparing pig high fever syndrome prevention medicine |
| 07/23/2008 | CN101224221A Application of NaCl in preparing medicine for treating pig pyrogenic syndrome |
| 07/23/2008 | CN101224186A Diclofenac epolamine jellies, preparing method and uses thereof |
| 07/23/2008 | CN101223940A Universal liquid feed specially for milk cow and preparing method thereof |
| 07/23/2008 | CN101223926A Compound ling herba artemisiae pearl milk tea preparation for turning children virus hepatitis |
| 07/23/2008 | CN100405062C Therapeutic and diagnostic uses of antibody specificity profiles |
| 07/23/2008 | CN100404065C Externally-applied medicinal liquid for treating rheumatalgia and wound and its preparation method |
| 07/23/2008 | CN100404064C Medicine composition having functions of resisting virus and clearing heat and preparing method |
| 07/23/2008 | CN100404042C Process for preparing soft capsule of red sage root and notoginseng |
| 07/23/2008 | CN100404033C Medicine composition for treating pulpitis |
| 07/23/2008 | CN100404031C Soft capsule composition containing zine gluconate, Ibuprofen and chlorphenamine maleate |
| 07/23/2008 | CN100404025C Oral disintegrating tablet containing tramadol hydrochloride and acetaminopher, and its preparation method |
| 07/23/2008 | CN100404022C Adhesive composition for dermal patch and production process thereof |
| 07/23/2008 | CN100404021C Medical super fire micro capsule capsaicine and its preparing method |
| 07/23/2008 | CN100404019C Multivesicular emulsion topical delivery systems |
| 07/22/2008 | US7402682 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates |
| 07/22/2008 | US7402669 Method for preparing a Centella asiatica extract rich in madecassoside and in terminoloside |
| 07/22/2008 | US7402662 Antibody molecules specific to human tumor necrosis factor alpha |
| 07/22/2008 | US7402660 Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a TEM protein |
| 07/22/2008 | US7402657 C-C chemokine receptor 3 proteins |
| 07/22/2008 | US7402655 Nucleotide sequences coding polypeptide for use in the treatment of canccer, inflamation and infectious disorders |
| 07/22/2008 | US7402609 Olopatadine formulations for topical administration |
| 07/22/2008 | US7402605 E.g., 17,17-propano-16-hydroxy-5-(4-ethoxycarbonylthiazol-2-yl)-9-oxo-1,2,3,4,20-pentanor-5-thia-8-azaprost-13-ene; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 07/22/2008 | US7402600 Nitroderivatives of cardiovascular agents |
| 07/22/2008 | US7402597 e.g. [[7-Allyl-3-[2-[2-(2,4-dichlorophenyl)-5-isopropyl-4-oxazolyl]ethyl]-1,2-benzisoxazol-6-yl]oxy]acetic acid; with vehicles (lactose, D-mannitol, glucose), disintegrators (starch or carboxymethylcellulose calcium ), binders (hydroxypropylcellulose) and lubricants (magnesium stearate or talc) |
| 07/22/2008 | US7402595 JNK inhibitor |
| 07/22/2008 | US7402580 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 07/22/2008 | US7402563 EPF derived peptides and therapeutic compositions |
| 07/22/2008 | US7402410 Humanized immunoglobulin reactive with α4β7 integrin |
| 07/22/2008 | CA2417825C 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 07/22/2008 | CA2383011C Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 07/22/2008 | CA2372840C Substituted bicyclic compounds |
| 07/17/2008 | WO2008085608A1 Compounds and compositions as channel activating protease inhibitors |
| 07/17/2008 | WO2008085484A2 Treatment of inflammatory bowel disease with enteric coated formulations comprising 5-aminosalicylic acid or 4-aminosalicylic acid |
| 07/17/2008 | WO2008084861A1 Condensed pyridine compound |
| 07/17/2008 | WO2008084805A1 Composition for external use |
| 07/17/2008 | WO2008084574A1 Anti-angiogenic agent |
| 07/17/2008 | WO2008084261A1 Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors |
| 07/17/2008 | WO2008083992A1 Use of gabab receptor selective agonists for treating inflammatory skin diseases |
| 07/17/2008 | WO2008067219A3 Quinazolinone modulators of tgr5 |
| 07/17/2008 | WO2008063300A3 Boronic acids and esters as inhibitors of fatty acid amide hydrolase |
| 07/17/2008 | WO2008030584A3 Indazole derivatives as modulators of interleukin- 1 receptor-associated kinase |
| 07/17/2008 | WO2008023278A3 1alpha-hydroxy-2- (3 ' -hydroxypropylidene) -19-n0r- vitamin d compounds with a 1,1-dimethylpropyl side chain |
| 07/17/2008 | WO2007080149A9 Treatment of stressed patients |
| 07/17/2008 | US20080171882 [(4S)-4-Methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride and [(4R)-4-methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride; chemical intermediates for enzyme inhibitors |
| 07/17/2008 | US20080171786 Substituted [(Phenylethanoyl)Amino]Benzamides |
| 07/17/2008 | US20080171778 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/17/2008 | US20080171770 e.g. 2-(6,7-difluoro-1H-benzimidazol-1-yl)-N-{1-[4-(trifluoromethyl)phenyl]ethyl}aceta mide; vanilloid receptor 1 (VR1 or TRPV1) antagonist; antiinflammatory agent; neuropathic pain; arthritis, ischaemia, fibromyalgia, asthma, cough, inflammatory bowel disease, obesity |
| 07/17/2008 | US20080171741 e.g. 5-(4-Chlorophenyl)-N-(5-(cyclopropylcarbamoyl)-2-methylphenyl)furan-2-carboxamide; p38 alpha and beta kinase inhibitor; antiinflammatory agent; asthma, inflammatory bowel disease, osteoporosis, psoriasis, graft vs. host rejection, atherosclerosis, multiple myeloma, pain, myocardial ischemia |
| 07/17/2008 | US20080171733 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine |
| 07/17/2008 | US20080171724 Phosphonate Derivatives of Mycophenolic Acid |
| 07/17/2008 | US20080171090 Dispersing core fine particles and coating layer comprising lipids or surfactants in liquid containing a polar solvent in which coating layer is soluble such that core fine particles are not dissolved; drug delivery of genes, DNA, RNA, oligonucleotides, plasmids, and/or siRNA; foods; antitumor agents |
| 07/17/2008 | US20080171081 Administering liposomes carrying phosphate-glycerol groups; inhibiting and/or reducing the progression of the T-cell function-mediated disorder; antiinflammatory |
| 07/17/2008 | US20080171041 Method for treating inflammation |
| 07/17/2008 | US20080171036 Using tumor necrosis factor specific immuoglobulin for diagnosis, treatment and prevention of inflammatory, cell proliferative, skin, respiratory system, nervous system and infectious disorders |
| 07/17/2008 | US20080171021 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 07/17/2008 | US20080171016 Death Domain Containing Receptors |
| 07/17/2008 | DE60130743T2 Mikrokugeln zur aktiven embolisierung Microspheres for embolization active |
| 07/17/2008 | CA2675288A1 Condensed pyridine compound |
| 07/17/2008 | CA2673803A1 Compounds and compositions as channel activating protease inhibitors |
| 07/16/2008 | EP1944292A1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 07/16/2008 | EP1944035A1 Method for reducing pain using oncolytic viruses |